The monthly dose can be up to 4 fold higher than weekly dose amount, can should lead to higher Cmax and theoretically more AUC than weekly doses to maintain similar efficacy
In 2015, Glenmark was the first to launch the DPP4 inhibitor, Teneligliptin (Zita Plus and Ziten), followed by a FDC of Teneligliptin + Metformin (Zita-Met Plus and Ziten-M)
The FDA Has Noticed, Too The FDA has highlighted the potential risk of fractures with some GLP-1 medications
Symptoms of deficiency The most common symptoms of niacin deficiency involve the skin, the digestive system, and the nervous system
Analytical verification of the peptide is commonly performed using: high-performance liquid chromatography (HPLC) mass spectrometry These analytical techniques allow researchers to confirm peptide purity, molecular identity, and structural integrity before experimental use